Free release
4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one

4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one

CAS No. :1443211-72-0MDL No. :MFCD28963966Formula :C21H16F3N3O3Boiling Point :-Linear Structure Formula :-InChI Key :YNU

Sales:Service@apichina.com
CAS No. :1443211-72-0 Brand :Qitai
Formula :C21H16F3N3O3 M.W :415.37

Introduction

CAS No. :1443211-72-0 MDL No. :MFCD28963966
Formula : C21H16F3N3O3 Boiling Point : -
Linear Structure Formula :- InChI Key :YNUAEEJQYHYLMS-UHFFFAOYSA-N
M.W : 415.37 Pubchem ID :71183216
Synonyms :

Physicochemical Properties

Num. heavy atoms : 30
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.19
Num. rotatable bonds : 5
Num. H-bond acceptors : 8.0
Num. H-bond donors : 0.0
Molar Refractivity : 104.83
TPSA : 64.55 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.18 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.28
Log Po/w (XLOGP3) : 3.74
Log Po/w (WLOGP) : 4.8
Log Po/w (MLOGP) : 1.95
Log Po/w (SILICOS-IT) : 4.01
Consensus Log Po/w : 3.56

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.89
Solubility : 0.00541 mg/ml ; 0.000013 mol/l
Class : Moderately soluble
Log S (Ali) : -4.79
Solubility : 0.00677 mg/ml ; 0.0000163 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.42
Solubility : 0.0000157 mg/ml ; 0.0000000378 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.03
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: